Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of its COVID products shrink
Read served as CEO until Albert Bourla took the position in 2019. Bourla was instrumental in working with BioNTech to develop a COVID-19 vaccine
Starboard has also approached Ian Read, a former Pfizer CEO, and Frank D'Amelio, who served as CFO until 2021, and both have expressed interest in helping the activist investor
The US company intends to sell 540 million Haleon shares, according to a statement on Monday
The northward movement in the rally follows the announcement of a whopping 350 per cent dividend, or Rs 35 per share, for FY24
The companies collectively are facing thousands of lawsuits against them in courts across the United States
The market for pharmaceutical products used in managing Covid-19 has shrunk by billions of dollars a year, including for Pfizer's vaccines and treatments
Not just AstraZeneca, but Pfizer and Roche have also set up their centres in the state
Moderna had argued Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the Covid-19 pandemic began in late 2019
The lawsuit filed by Kansas, a US state, alleged that Pfizer promoted its vaccine's safety while hiding evidence linking it to pregnancy complications, such as miscarriages, and heart inflammations
Their investment pledges came as President Emmanuel Macron prepared to kick off on Monday the annual 'Choose France' event aimed at wooing big overseas businesses and investors
Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn
Delhi HC has ordered Renovision Exports to pay Pfizer Rs 3 lakh and issued a permanent injunction preventing the marketing of homoeopathic medicine under the 'VIGOURA' mark
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of COVID-19
The Pfizer INDovation initiative, which has supported 34 startups in India till now, is now expanding its reach through this collaboration with NIPER Ahmedabad
Attorneys for Lipitor purchasers including Rochester Drug Co-Operative Inc and Puerto Rico's Drogueria Betances LLC disclosed the agreement in a filing on Wednesday in US court in Trenton, New Jersey
Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market
The prevalence of atopic dermatitis in India has risen over the past three decades, with approximately 5.9 per cent of adults affected, of which 4.4 per cent suffer from a severe form of the disease
The New York-based drugmaker earned 10 cents per share on an adjusted basis for the fourth quarter. Analysts on average had expected a loss of 22 cents per share, according to LSEG data
Drug firm Pfizer Ltd on Saturday reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023. The company had logged a net profit of Rs 311.07 crore in July-September period a year ago, according to a regulatory filing by Pfizer. Revenue from operations declined 9.76 per cent to Rs 575.21 crore in the quarter as against Rs 637.47 crore in the year-ago period. Total expense was at Rs 410.76 crore, down 5.66 per cent. Total income was at Rs 611.28 crore in September quarter 2023-24, down 7.62 per cent.